Request Demo
Last update 14 Mar 2026
Naproxen/Phosphatidylcholine
Last update 14 Mar 2026
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms PL-3100 |
Target |
Action inhibitors |
Mechanism COX inhibitors(Cyclooxygenases inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Login to view timeline
Structure/Sequence
Molecular FormulaC14H14O3 |
InChIKeyCMWTZPSULFXXJA-VIFPVBQESA-N |
CAS Registry22204-53-1 |
Related
2
Clinical Trials associated with Naproxen/PhosphatidylcholineNCT01139190
A Phase 2 Clinical Trial Evaluating the Incidence of Upper Gastrointestinal Mucosal Damage Following Administration of Either PL3100 or Naproxen in Subjects Who Are at Risk for Developing NSAID-Associated GI Damage
NCT00966641
"A Single-Dose Crossover Oral Bioequivalence Study of PL 3100 and Naproxen in Healthy Adult Volunteers in the Fasted State"
100 Clinical Results associated with Naproxen/Phosphatidylcholine
Login to view more data
100 Translational Medicine associated with Naproxen/Phosphatidylcholine
Login to view more data
100 Patents (Medical) associated with Naproxen/Phosphatidylcholine
Login to view more data
100 Deals associated with Naproxen/Phosphatidylcholine
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Gastrointestinal mucosal disorder | Phase 2 | United States | 01 Jul 2010 | |
| Peptic Ulcer | Phase 2 | United States | 01 Jul 2010 | |
| Arthritis | Phase 2 | - | - |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Phase 2 | 77 | (PL3100) | aizblejzkf = jlhnngwmmb emsubugltv (tgvmisbfng, wxxndhaxde - hzompxohar) View more | - | 11 Apr 2016 | ||
(Naproxen) | aizblejzkf = vggazyxtav emsubugltv (tgvmisbfng, tbdspqonxo - hafksvjuuw) View more | ||||||
Phase 1/2 | - | 34 | (PL 3100) | npgqpblhkc(pwevyhhkfu) = betltgmhmo lrgdvlestc (ojmkxblnza, wxyngxjadn - ehcjbupiuq) View more | - | 07 Sep 2015 | |
(Naproxen) | npgqpblhkc(pwevyhhkfu) = vxfkhakmcu lrgdvlestc (ojmkxblnza, dhufchoyne - jpblglghso) View more |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free